Get an in-depth insight of one of the leading biotech investors
«The biotech sector is leading the effort against the pandemic through approved mRNA vaccines and therapeutic antibodies»
Dr. Erich Hunziker
Interview Head Investment Team
Dr. Daniel Koller looks back at 2020 and explains the breakthroughs in the biotech industry, why BB Biotech had already invested in Moderna in 2018, and the new additions to the portfolio.
Portfolio Update Q4 2020
The fourth quarter 2020 provided multiple major milestones for our portfolio holdings such as clinical results, regulatory decisions, licensing deals and M&A transactions.